# Dexlansoprazole

## Dexilant delay-release 60mg

##### 

| TAH Drug Code      | [ODEXI](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ODEXI)                                                                                                                                                                                                                         |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Healing & maintenance of all grades of erosive esophagitis. Treatment of heartburn associated w/ symptomatic non-erosive GERD.                                                                                                                                                                 |
| Dosing             | Erosive esophagitis, Healing of all grades Age > 12 years-old, 60 mg orally once daily for up to 8 weeks. Erosive esophagitis, Maintenance of healing - Heartburn 30 mg orally once daily for up to 6 months. Gastroesophageal reflux disease, nonerosive 30 mg orally once daily for 4 weeks. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                  |
| Contraindications  | Hypersensitivity & anaphylaxis.                                                                                                                                                                                                                                                                |
| Adverse Effects    | Diarrhea, abdominal pain, nausea, upper resp tract infection, vomiting & flatulence.                                                                                                                                                                                                           |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                   |

